Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study

Aliment Pharmacol Ther. 2006 Jun 1;23(11):1615-9. doi: 10.1111/j.1365-2036.2006.02907.x.

Abstract

Background: Treatment of oesophageal achalasia with intrasphincteric injections of botulinum toxin has proved to be a successful alternative treatment modality. However, little is known about its long-term effects in very old patients.

Aim: To evaluate the effects of such treatment in octo-nonagerians during a 2-year follow-up period.

Patients and methods: Thirty-three patients with idiopathic oesophageal achalasia (range 81-94 years) entered the study. After basal evaluation and screening procedures, 100 U of botulinum toxin was injected at the lower oesophageal sphincter, and the procedure was repeated 1 month later. Data were collected at baseline and were compared after 1 and 2 years following the procedure.

Results: Seventy-eight per cent of patients were considered responders at 1 year and 54% were considered responders at 2 years. The weight gain at the end of the follow-up period was 2 (0-3) kg. No significant relationship was found between baseline lower oesophageal sphincter pressure and symptoms score after 1 and 2 years of follow-up; moreover, no major complications of botulinum toxin therapy were reported.

Conclusion: Treatment of very old achalasic patients with botulinum toxin is safe, effective and yields good quality of life in a substantial proportion of these subjects.

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Botulinum Toxins / therapeutic use*
  • Esophageal Achalasia / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections
  • Male
  • Treatment Outcome

Substances

  • Botulinum Toxins